Source briefingJuly 29, 2026Health & Science
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 July 2026

Source briefing · A concise briefing based on one linked source. It is intentionally shorter than a full FreedomWitness Evidence Engine analysis.
What the source reports
Twelve new medicines recommended for approvalEMA’s human medicines committee (CHMP) recommended twelve medicines for approval at its July 2026 meeting.The committee…, CHMP statistics Key figures from the July 2026 CHMP meeting are represented in the graphic below.
© European Medicines Agency , CHMP statistics:…, Positive recommendations on new medicines, Evlarco International non-proprietary name (INN) obicetrapib / ezetimibe Marketing authorisation applicant A.…
Evidence note: At this stage FreedomWitness is presenting what this source reports. This briefing does not independently prove every underlying claim and should be read together with the original material.
Source & verification
Primary source: News and press releases · July 24, 2026
FreedomWitness links to the original source so readers can inspect the underlying material and judge the context for themselves.
Continue reading

Correction: Co-exposure to planned power outages and wildfire PM<sub>2.5</sub> and acute healthcare utilization in California: A time-stratified case-crossover study
Health Impacts of Planned Power Outages and Wildfire Smoke Exposure in California: Analysis of Recent Research Recent research published in PLOS Medicine investigates the…

Harvard-led team receives $12 million in federal funds to advance quantum computing with AI
Evidence Dossier: Harvard-Led Quantum Computing Initiative with Federal Funding What is established A collaborative research project led by Harvard University has secured $12 million…

US Tries but Fails to Dilute UN Human Rights Resolutions
US Attempts to Weaken UN Human Rights Resolutions: An Evidence Review What is established In late 2026, during sessions of the United Nations General…